[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
October 2014

Venous Thromboembolism Prophylaxis for Medical PatientsWho Needs It?

Author Affiliations
  • 1Center for Value-Based Care Research, Medicine Institute, Cleveland Clinic, Cleveland, Ohio
JAMA Intern Med. 2014;174(10):1585-1586. doi:10.1001/jamainternmed.2014.3357

In medicine, the quality and safety movement attempts to improve processes of care through careful measurement and application of industrial quality improvement techniques. When outcomes are publicly reported or tied to reimbursement, hospitals’ ability to improve their performance has been impressive. On the other hand, choosing what to measure has been more challenging, and several measures that were formerly tied to reimbursement have been revised or rescinded. Moreover, quality measures have rarely allowed for personalization, such as adjusting hemoglobin A1C targets for age or mammography rates for patient preference. In this issue of JAMA Internal Medicine, Flanders et al1 report on one such measure that should be entirely personalized—venous thromboembolism (VTE) prophylaxis.

First Page Preview View Large
First page PDF preview
First page PDF preview